Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) — Stock Score Summary

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) has a MoatMap StockRank of 98/100 based on Quality (73/100), Value (63/100), and Momentum (57/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$4.12
Market Cap$3.8B
P/E (TTM)15.26
P/E (Forward)8.66
Price/Book1.75
Return on Equity11.5%
Return on Invested Capital14.7%
Debt/Equity7.08
Gross Margin80.0%
Operating Margin32.1%
Revenue Growth-20.8%
Dividend Yield7.5%
Free Cash Flow$19M

Hubei Jumpcan Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hubei Jumpcan Pharmaceutical Co., Ltd.’s (600566.SS) StockRank?
MoatMap’s StockRank for Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) is 98/100, with a Strong Buy signal. It is a composite of Quality (73), Value (63), and Momentum (57) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hubei Jumpcan Pharmaceutical Co., Ltd. have an economic moat?
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hubei Jumpcan Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hubei Jumpcan Pharmaceutical Co., Ltd. in?
Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).